je.st
news
AstraZeneca plc (AZN) Receives "Buy" Rating from Jefferies Group
2016-01-04 06:49:41| Biotech - Topix.net
's stock had its "buy" rating reiterated by Jefferies Group in a note issued to investors on Thursday, ARN reports. They currently have a GBX 5,600 target price on the biopharmaceutical company's stock.
Tags: group
buy
rating
receives
Category:Biotechnology and Pharmaceuticals